➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: June 20, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Sym004

Email this page to a colleague

« Back to Dashboard

What is the drug development status for Sym004?

Sym004 is an investigational drug.

There have been 11 clinical trials for Sym004. The most recent clinical trial was a Phase 2 trial, which was initiated on February 1st 2019.

The most common disease conditions in clinical trials are Colorectal Neoplasms, Carcinoma, and Colonic Neoplasms. The leading clinical trial sponsors are Symphogen A/S, EMD Serono, and Merck KGaA.

There are two US patents protecting this investigational drug and thirty-seven international patents.

Recent Clinical Trials for Sym004
Sym004 Versus TAS-102 in Patients With mCRCSymphogen A/SPhase 3
Sym004 Versus Futuximab or Modotuximab in Patients With mCRCSymphogen A/SPhase 2
Sym004 in Metastatic Colorectal Cancer and ECD-EGFR PatientsSymphogen A/SPhase 2

See all Sym004 clinical trials

Clinical Trial Summary for Sym004

Top disease conditions for Sym004
Top clinical trial sponsors for Sym004

See all Sym004 clinical trials

US Patents for Sym004

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Sym004   Try Before You Buy Binding molecules specific for HER3 and uses thereof MEDIMMUNE, LLC (Gaithersburg, MD)   Try Before You Buy
Sym004   Try Before You Buy Methods for assessing and identifying or evolving conditionally active therapeutic proteins Halozyme, Inc. (San Diego, CA)   Try Before You Buy
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.